Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRhythm Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 8 | -$1.03 | -$0.53 | -$0.78 |
| Q2 2026 | 5 | -$0.81 | -$0.59 | -$0.72 |
| Q3 2026 | 3 | -$0.74 | -$0.54 | -$0.66 |
| Q4 2026 | 5 | -$0.69 | -$0.50 | -$0.61 |
| Q1 2027 | 3 | -$0.21 | -$0.15 | -$0.18 |
| Q2 2027 | 5 | -$0.08 | -$0.06 | -$0.07 |
| Q3 2027 | 3 | $0.18 | $0.24 | $0.21 |
| Q4 2027 | 5 | $0.38 | $0.52 | $0.46 |
Rhythm Pharmaceuticals Inc. Earnings Date And Information
Rhythm Pharmaceuticals Inc. last posted its earnings results on Tuesday, November 4th, 2025. The company reported $-0.82 earnings per share for the quarter, missing analysts' consensus estimates of $-0.72 by $0.1. The company had revenue of 51.30 M for the quarter and had revenue of 130.13 M for the year. Rhythm Pharmaceuticals Inc. has generated $-4 earnings per share over the last year ($-4.34 diluted earnings per share) and currently has a price-to-earnings ratio of -33.85. Rhythm Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Rhythm Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2025 | Q3 2025 | -$0.72 | -$0.82 | -0.1 | $50.71 M | $51.30 M |
| 08/05/2025 | Q2 2025 | -$0.66 | -$0.75 | -0.09 | $43.64 M | $48.50 M |
| 05/07/2025 | Q1 2025 | -$0.69 | -$0.81 | -0.12 | N/A | $32.70 M |
| 02/28/2025 | Q4 2024 | N/A | -$0.72 | N/A | N/A | $41.83 M |
| 11/06/2024 | Q3 2024 | N/A | -$0.71 | N/A | $32.52 M | $33.25 M |
| 08/14/2024 | Q2 2024 | N/A | -$0.53 | N/A | $28.79 M | $29.08 M |
| 05/07/2024 | Q1 2024 | -$2.34 | -$2.35 | -0.01 | N/A | $25.97 M |
| 02/29/2024 | Q4 2023 | N/A | -$0.70 | N/A | N/A | $24.23 M |
| 11/08/2023 | Q3 2023 | N/A | -$0.76 | N/A | N/A | $22.50 M |
| 08/01/2023 | Q2 2023 | -$0.80 | -$0.82 | -0.02 | N/A | $19.22 M |
| 05/02/2023 | Q1 2023 | -$0.71 | -$0.91 | -0.2 | N/A | $11.47 M |
| 03/01/2023 | Q4 2022 | -$0.82 | -$0.75 | 0.07 | N/A | $8.79 M |
| 11/08/2022 | Q3 2022 | -$1.01 | -$0.83 | 0.18 | N/A | $4.28 M |
| 08/03/2022 | Q2 2022 | N/A | -$0.89 | N/A | N/A | $9.07 M |
| 05/03/2022 | Q1 2022 | -$0.98 | -$1.05 | -0.07 | N/A | $1.50 M |
| 03/01/2022 | Q4 2021 | -$1.00 | -$0.85 | 0.15 | N/A | $1.82 M |
| 11/02/2021 | Q3 2021 | -$0.84 | -$0.70 | 0.14 | N/A | $1.03 M |
| 08/03/2021 | Q2 2021 | -$0.75 | -$0.70 | 0.05 | N/A | $274.00 K |
| 05/03/2021 | Q1 2021 | -$0.23 | $0.92 | 1.15 | N/A | $35.00 K |
| 03/01/2021 | Q4 2020 | -$0.81 | -$0.79 | 0.02 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rhythm Pharmaceuticals Inc. Earnings: FAQ's
The conference call for Rhythm Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Rhythm Pharmaceuticals Inc.'s latest earnings report can be read online.
Rhythm Pharmaceuticals Inc. (:RYTM) has a recorded annual revenue of $130.13 M.
Rhythm Pharmaceuticals Inc. (:RYTM) has a recorded net income of $-260,602,000.Rhythm Pharmaceuticals Inc. has generated $-4.34 earnings per share over the last four quarters.
Rhythm Pharmaceuticals Inc. (:RYTM) has a price-to-earnings ratio of -33.85 and price/earnings-to-growth ratio is 9.2.